1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for GYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2007. Start Trial.
Date Value
September 15, 2026 -15.32%
September 14, 2026 -14.56%
September 11, 2026 -17.12%
September 10, 2026 -17.50%
September 09, 2026 -9.39%
September 08, 2026 -9.13%
September 04, 2026 -9.50%
September 03, 2026 -20.30%
September 02, 2026 -17.51%
September 01, 2026 -16.41%
August 31, 2026 -15.12%
August 28, 2026 -20.41%
August 27, 2026 -17.63%
August 26, 2026 -14.30%
August 25, 2026 -18.54%
August 24, 2026 -21.27%
August 21, 2026 -8.48%
August 20, 2026 -9.18%
August 19, 2026 -5.05%
August 18, 2026 -11.08%
August 17, 2026 -16.34%
August 14, 2026 -18.73%
August 13, 2026 -20.34%
August 12, 2026 -11.90%
August 11, 2026 -6.08%
Date Value
August 10, 2026 -6.54%
August 07, 2026 -7.36%
August 06, 2026 -8.83%
August 05, 2026 -9.97%
August 04, 2026 -12.39%
August 03, 2026 -8.12%
July 31, 2026 -18.44%
July 30, 2026 -20.08%
July 29, 2026 -22.74%
July 28, 2026 -23.30%
July 27, 2026 -19.76%
July 24, 2026 -19.51%
July 23, 2026 -20.61%
July 22, 2026 -17.84%
July 21, 2026 -14.65%
July 20, 2026 -18.45%
July 17, 2026 -18.13%
July 16, 2026 -13.36%
July 15, 2026 -8.38%
July 14, 2026 -16.69%
July 13, 2026 -15.35%
July 10, 2026 -16.52%
July 09, 2026 -14.25%
July 08, 2026 -15.52%
July 07, 2026 -8.01%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Cytokinetics, Inc. 40.19%
ACADIA Pharmaceuticals, Inc. 8.47%
Alnylam Pharmaceuticals, Inc. -48.33%
Anika Therapeutics, Inc. 141.7%
Savara, Inc. 45.71%